A Phase 1 study of ONO-7056 in patients with solid tumor
Latest Information Update: 26 Aug 2019
At a glance
- Drugs Salirasib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Ono Pharmaceutical
- 02 Jun 2016 New trial record
Latest Information Update: 26 Aug 2019